[Skip to Navigation]
Editor's Correspondence
May 28, 2012

Fecal Transplant for Clostridium difficile

Author Affiliations

Author Affiliations: Alta Bates Summit Medical Center, Department of Medicine, University of California, San Francisco, Oakland (Dr Stollman); and Department of Medicine, University of Washington, Seattle (Dr Surawicz).

Arch Intern Med. 2012;172(10):825-826. doi:10.1001/archinternmed.2012.1055

Kassam and colleagues1 are to be congratulated on their series of patients successfully treated with “fecal transplant” for refractory or recurrent Clostridium difficile–related disease, demonstrating greater than 90% success rates—highly consistent with prior data, including ours.2

Add or change institution